Funding for this research was provided by:
Institute of Psychiatry, Psychology and Neuroscience, King’s College London
MRC (MC-A656-5QD30)
Article History
Received: 6 December 2018
Accepted: 7 February 2019
First Online: 18 March 2019
Compliance with ethical standards
:
: Dr. Ashok conducts research funded by the Medical Research Council (UK) and King’s College London. Dr. Mizuno has received manuscript fees or speaker’s honoraria from Sumitomo Dainippon Pharma and Yoshitomi Yakuhin, fellowship grants from Japan Society for the Promotion of Science, Astellas Foundation for Research on Metabolic Disorders, Japanese Society of Clinical Neuropsychopharmacology, and Mochida Memorial Foundation for Medical and Pharmaceutical Research, and consultant fees from Bracket within the past 3 years. Prof. Howes conducts research funded by the Medical Research Council (UK), the National Institute of Health Research (UK), and the Maudsley Charity. Prof Howes has received investigator-initiated research funding from and/or participated in advisory/speaker meetings organized by Astra-Zeneca, BMS, Eli Lilly, Jansenn, Lundbeck, Lyden-Delta, Servier, and Roche. Neither Prof. Howes nor his family have been employed by or have holdings/of a financial stake in any biomedical company.